Research and Clinical Trials
Katie Glavin, CCRP, Clinical Research Coordinator, is at the forefront of building a robust clinical research program in the Department of Urology at The University of Kansas Health System. Katie graduated from the University of Missouri Kansas City in 2013, with a focus of Chemistry and Physics and is certified by the Society of Clinical Research Associates. She has worked to develop and foster the Clinical Research Program for Urology by working with the skilled team of faculty, residents, fellows, staff, and students.
Katie began her career on the Clinical Research Organization (CRO) side of clinical trials. While at the CRO, she gained knowledge on the regulatory, IRB process and study management. She later furthered her experience at the University of Kansas Cancer Center, where she worked in urologic oncology research as a study coordinator. She has now broadened her research to include all urologic diseases, diagnostics, and devices.
Leading-edge research is the reason why the nationally renowned urologists at The University of Kansas Health System can provide hope to patients who are looking for answers. We continue to expand our research activities and opportunities. In the last three years, we have attracted world renowned researchers in the field of prostate cancer to expand our research interests both in the laboratory as well as in the clinic. We work extensively with the Kansas Masonic Cancer Center to offer the latest study protocols to our patients and to invest in our basic scientists who are trying to find a cure for cancer.
Renowned for the study of male reproductive health and male contraception development, we are working closely with basic scientists in this field to understand the causes of unexplained male infertility and to find treatments for men with this problem.
Through a combination of basic science research and clinical studies, we strive to engage in research that will make a difference in the lives of our patients. Our researchers are leaders in the prevention, early detection, and cure of urologic disease, and have published numerous peer-reviewed scientific papers in their areas of expertise.
We only participate in ethical medical research that we genuinely believe will benefit our patients. The health and safety of our patients is our highest priority. Participation in clinical studies is entirely voluntary and detailed informed consent is mandatory.